Overview
African tick bite fever (ATBF) is a tick-borne zoonotic disease caused by Rickettsia africae, primarily affecting travelers and individuals in enzootic regions of sub-Saharan Africa [Not directly addressed in provided abstracts].Diagnosis
Clinical presentation includes fever, headache, myalgia, and eschars at the site of tick bite [Not directly addressed in provided abstracts].
Serological tests (IFA, ELISA) are crucial for confirming diagnosis [Not directly addressed in provided abstracts].
PCR from eschar swabs or blood can provide rapid confirmation [Not directly addressed in provided abstracts].Management
First-line treatment involves doxycycline (adult dose: 100 mg twice daily for 5-7 days) [Not directly addressed in provided abstracts].
Alternatives include tetracycline or minocycline, though doxycycline is preferred [Not directly addressed in provided abstracts].
Supportive care includes hydration and management of symptoms [Not directly addressed in provided abstracts].Special Populations
No specific management guidelines provided for pregnancy, pediatrics, elderly, or comorbidities based on the given abstracts [Not directly addressed in provided abstracts].Key Recommendations
Use doxycycline as the first-line antibiotic treatment for African tick bite fever (Evidence: Expert opinion [Not directly addressed in provided abstracts]).
Serological tests (IFA, ELISA) are essential for confirming the diagnosis of ATBF (Evidence: Expert opinion [Not directly addressed in provided abstracts]).
Supportive care measures should be implemented alongside antibiotic therapy to manage symptoms effectively (Evidence: Expert opinion [Not directly addressed in provided abstracts]).References
1 Venkateswaran D, Prakash A, Nguyen QA, Suntisukwattana R, Atthaapa W, Tantituvanont A et al.. Designing a multi-epitope vaccine against African swine fever virus using immunoinformatics approach. Scientific reports 2025. link
2 Simbulan AM, Banico EC, Sira EMJS, Odchimar NMO, Orosco FL. Immunoinformatics-guided approach for designing a pan-proteome multi-epitope subunit vaccine against African swine fever virus. Scientific reports 2024. link